Read More Analyst Ratings News Price Target Upgrades B of A Securities Upgrades Meta Platforms to Buy, Announces $220 Price Target By Benzinga Newsdesk February 2, 7:50 AM B of A Securities analyst Justin Post upgrades Meta Platforms (NASDAQ:META) from Neutral to Buy and announces $220 price target. META
Read More News Tech Samsung Said it Will More than Triple Advanced Chip Output by 2027 By Charles Gross October 4, 6:40 AM -Nikkei https://asia.nikkei.com/Business/Tech/Semiconductors/Samsung-says-it-will-more-than-triple-advanced-chip-output-by-2027 SSNLF
Read More Biotech General News IN8bio Announces Publication On Novel Gamma-Delta T Cell Therapy For Glioblastoma In Frontiers In Immunology By Benzinga Newsdesk February 14, 9:17 AM IN8bio, Inc. (NASDAQ:INAB), a leading clinical-stage biopharmaceutical company developing innovative gamma-delta T cell therapies, today announced a publication in Frontiers in Immunology that reviews IN8bio's novel INAB
Read More General Markets News JPMorgan Chase CEO Jamie Dimon Issues Stark Warning Amid Israel-Hamas War: ‘The Most Dangerous Time In Decades’ By Benzinga Neuro October 14, 12:23 AM Jamie Dimon voiced concern about intensifying global threats, labeling these times as some of the most perilous in recent decades. JPM